Preliminary Data from Phase 1 Trial for Multiple Myeloma Indicates Complete Response in a Patient

Phase 1 Trial A Phase 1 trial by Gamida Cell is examining a new potential treatment option for patients with multiple myeloma and relapsed/refractory non-Hodgkin's lymphoma who have not responded…

Continue Reading Preliminary Data from Phase 1 Trial for Multiple Myeloma Indicates Complete Response in a Patient

New Phase I/II Trial for Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Multiple Myeloma is Now Underway!

The very first patient in Medigene AG's clinical trial examining MDG1011 has officially received the treatment. This is the company's first human clinical trial for this TCR therapy. The trial…

Continue Reading New Phase I/II Trial for Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Multiple Myeloma is Now Underway!

Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients

What is the Patient Advocate Foundation? The Patient Advocate Foundation (PAF) is a non-profit, formed in 1994 that has one primary aim- eliminate the barriers to treatment too many patients…

Continue Reading Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients

1 Million to Fund Software Which Could Improve Treatment Plans for Multiple Myeloma Patients

We've made a lot of progress in cancer research in recent years. Many novel therapies have been developed for illnesses previously considered untreatable. However, as new treatments have been discovered,…

Continue Reading 1 Million to Fund Software Which Could Improve Treatment Plans for Multiple Myeloma Patients
Research Updates for Multiple Myeloma and WM!
Source: Pixabay.com

Research Updates for Multiple Myeloma and WM!

Dana-Farber Cancer Institute has just announced research updates on multiple myeloma and waldenstrom macroglobulinemia which indicate significant progress in the search for treatments for these diseases. The Findings 1) There…

Continue Reading Research Updates for Multiple Myeloma and WM!
Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia
crystal710 / Pixabay

Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia

According to a story from PR Newswire, the 60th Annual Meeting of the American Society of Hematology has been generating a lot of press lately as many groundbreaking studies, research,…

Continue Reading Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia
Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
mwooten / Pixabay

Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment

According to a story from BioPortfolio, Celgene Corporation and bluebird bio, Inc., have recently announced that enrollment for a pivotal Phase 2 study testing an experimental therapy for relapsed/refractory multiple…

Continue Reading Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment

Working to Improve Gene Therapy for Adrenoleukodystrophy and Other Rare Conditions

Rare disease research is often underrepresented in the field of science. However, recent developments have made researchers more interested in studying this group of diseases. For instance, investments in gene…

Continue Reading Working to Improve Gene Therapy for Adrenoleukodystrophy and Other Rare Conditions
CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma
source: pixabay.com

CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma

According to a story from Hematology Times, an experimental CAR-T cell therapy called P-BCMA-101 was recently granted regenerative medicine advanced therapy (RMAT) designation from the US Food and Drug Administration.…

Continue Reading CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma
Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
allinonemovie / Pixabay

Rare Blood Cancer Trial Data to be Presented in Upcoming Conference

According to a story from investors.amgen.com, the drug developer Amgen recently announced its intent to present all new clinical trial data which will feature its latest work in testing a…

Continue Reading Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
Clinical Trials For Multiple Myeloma and Other Diseases Fail to Reflect Racial Demographics
Pexels / Pixabay

Clinical Trials For Multiple Myeloma and Other Diseases Fail to Reflect Racial Demographics

According to a story from Mother Jones, patients of black or Native American backgrounds are consistently underrepresented in clinical trials. This occurs even when the trials are for diseases that…

Continue Reading Clinical Trials For Multiple Myeloma and Other Diseases Fail to Reflect Racial Demographics
Researchers Have Found Which Common Blood Tests are the Most Effective for Identifying Multiple Myeloma
jarmoluk / Pixabay

Researchers Have Found Which Common Blood Tests are the Most Effective for Identifying Multiple Myeloma

A team of researchers led by Constantinos Koshiaris from the University of Oxford have recently published a study that investigated the best way to identify multiple myeloma through blood tests.…

Continue Reading Researchers Have Found Which Common Blood Tests are the Most Effective for Identifying Multiple Myeloma
Scientist from USC is Designing a New Tool to Personalize Care for Cancer Patients and Guide Treatment
Source: Pixabay.com

Scientist from USC is Designing a New Tool to Personalize Care for Cancer Patients and Guide Treatment

According to a story from HSC News, Dr. Peter Kuhn from the University of South Carolina (USC) is developing a navigational tool that aims to personalize treatment based on a…

Continue Reading Scientist from USC is Designing a New Tool to Personalize Care for Cancer Patients and Guide Treatment

ICYMI: Researchers Develop a New Immunotherapy Technique Using Electric Shocks

According to a story from the Washington Post, a new technique for delivering genes into immune system T cells could make immunotherapy a much more accessible option for treating rare…

Continue Reading ICYMI: Researchers Develop a New Immunotherapy Technique Using Electric Shocks

Melflufen Could be a New Treatment Option for Multiple Myeloma

According to a story from Hematology Times, a medicine called melflufen, of the alkylating peptide class, appears to be effective in treatment resistant multiple myeloma. In a Phase 2 trial,…

Continue Reading Melflufen Could be a New Treatment Option for Multiple Myeloma
Close Menu